Alkanil (450 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Inga Laboratories Pvt. Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Disodium Hydrogen Citrate, Dipotassium Hydrogen Citrate. This drug comes in the form of Syrup. The general packing available for this medicine consists of 450 ml and is priced at Rs 95 (arround $1.33 US Dollar)
The main active ingredients or salts in Alkanil (450 ml) are :
Dipotassium Hydrogen Citrate-625 mg
Disodium Hydrogen Citrate-625 mg
Disodium Hydrogen Citrate Indication (Prescribed for or used as):
For more details on Disodium Hydrogen Citrate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Disodium Hydrogen Citrate..
Dipotassium Hydrogen Citrate Indication (Prescribed for or used as):
For more details on Dipotassium Hydrogen Citrate, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Dipotassium Hydrogen Citrate..
Alkanil (450 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 0 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Alkanil (450 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Dipotassium Hydrogen Citrate-625 mg Disodium Hydrogen Citrate-625 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.